Archives of Clinical Infectious Diseases

Published by: Kowsar

Comparing Tuberculosis Incidence in a Prison with the Society, Tehran, Iran

Seyedahmad Seyedalinaghi 1 , Behnam Farhoudi 2 , * , Zeinab Najafi 3 , Sirous Jafari 1 and Mohammad Shahbazi 4
Authors Information
1 Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
2 Clinical Research Development Center, Amir-Almomenin Hospital, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
3 Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4 GFATM Project Coordinator against HIV/AIDS and Tuberculosis Projects, United Nations Development Program, Prisons Organization, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2018, 13 (2); e60247
  • Published Online: April 22, 2018
  • Article Type: Brief Report
  • Received: August 14, 2017
  • Accepted: September 19, 2017
  • DOI: 10.5812/archcid.60247

To Cite: Seyedalinaghi S, Farhoudi B, Najafi Z, Jafari S, Shahbazi M. Comparing Tuberculosis Incidence in a Prison with the Society, Tehran, Iran, Arch Clin Infect Dis. 2018 ; 13(2):e60247. doi: 10.5812/archcid.60247.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle. 1991;72(1):1-6. doi: 10.1016/0041-3879(91)90017-M. [PubMed: 1882440].
  • 2. Biadglegne F, Rodloff AC, Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect. 2015;143(5):887-900. doi: 10.1017/S095026881400288X. [PubMed: 25376279].
  • 3. Sretrirutchai S, Silapapojakul K, Palittapongarnpim P, Phongdara A, Vuddhakul V. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility. Int J Tuberc Lung Dis. 2002;6(3):208-14. [PubMed: 11934138].
  • 4. Henostroza G, Topp SM, Hatwiinda S, Maggard KR, Phiri W, Harris JB, et al. The high burden of tuberculosis (TB) and human immunodeficiency virus (HIV) in a large Zambian prison: a public health alert. PLoS One. 2013;8(8). e67338. doi: 10.1371/journal.pone.0067338. [PubMed: 23967048]. [PubMed Central: PMC3743881].
  • 5. Sanchez A, Gerhardt G, Natal S, Capone D, Espinola A, Costa W, et al. Prevalence of pulmonary tuberculosis and comparative evaluation of screening strategies in a Brazilian prison. Int J Tuberc Lung Dis. 2005;9(6):633-9. [PubMed: 15971390].
  • 6. Telisinghe L, Fielding KL, Malden JL, Hanifa Y, Churchyard GJ, Grant AD, et al. High tuberculosis prevalence in a South African prison: the need for routine tuberculosis screening. PLoS One. 2014;9(1). e87262. doi: 10.1371/journal.pone.0087262. [PubMed: 24498059]. [PubMed Central: PMC3907552].
  • 7. Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. 1998.
  • 8. Aerts A, Hauer B, Wanlin M, Veen J. Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis. 2006;10(11):1215-23. [PubMed: 17131779].
  • 9. Chan PC, Yang CH, Chang LY, Wang KF, Kuo YC, Lin CJ, et al. Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates. Thorax. 2013;68(3):263-8. doi: 10.1136/thoraxjnl-2012-202208. [PubMed: 23019256].
  • 10. Farhoudi B, SeyedAlinaghi SA, Mohraz M, Hosseini M, Farnia M. Tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison, Iran. Asian Pac J Tro Dis. 2016;6(1):82-3. doi: 10.1016/s2222-1808(15)60989-6.
  • 11. Farhoudi B, SeyedAlinaghi S, Tabarsi P, Mohraz M, Golrokhy R, Farnia M, et al. Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran. Infect Disord Drug Targets. 2018;18(1):72-80. doi: 10.2174/1871526517666170518093529. [PubMed: 28521672].
  • 12. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PLoS Med. 2010;7(12). e1000381. doi: 10.1371/journal.pmed.1000381. [PubMed: 21203587]. [PubMed Central: PMC3006353].
  • 13. Dara M, Chorgoliani D, de Colombani P. 8. TB prevention and control care in prisons. Prisons and Health. 2014. p. 56-72.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments